Concepedia

Emmanuel Deau

ED

Statistics

Publications

14

Citations

401

H-Index

14

Active since

2013

Affiliations

Centre National de la Recherche Scientifique(Current)

ManRos Therapeutics (France)

Laboratoire COBRA

Institut National des Sciences Appliquées Rouen Normandie

Normandie Université

Emmanuel Deau is an author at Centre National de la Recherche Scientifique specializing in medicinal chemistry, drug discovery, and pharmacy.

ORCID

Publications per year

2013–2024

14

Publications

14

Synthesis and molecular modelling studies of 8-arylpyrido[3′,2′:4,5]thieno[3,2-d]pyrimidin-4-amines as multitarget Ser/Thr kinases inhibitors

Yvonnick Loidreau, Emmanuel Deau, Pascal Marchand et al. · European Journal of Medicinal Chemistry · 2014 · 56 citations · Full text

, , +14

Chemical, Biochemical, Cellular, and Physiological Characterization of Leucettinib-21, a Down Syndrome and Alzheimer’s Disease Drug Candidate

Mattias F. Lindberg, Emmanuel Deau, Frédéric Miege et al. · Journal of Medicinal Chemistry · 2023 · 47 citations · Full text

, , +17

Comparative Efficacy and Selectivity of Pharmacological Inhibitors of DYRK and CLK Protein Kinases

Mattias F. Lindberg, Emmanuel Deau, Jonas Arfwedson et al. · Journal of Medicinal Chemistry · 2023 · 45 citations · Full text

, , +14

Increased dosage of DYRK1A leads to congenital heart defects in a mouse model of Down syndrome

Eva Lana‐Elola, Rifdat Aoidi, Miriam Llorian et al. · Science Translational Medicine · 2024 · 44 citations · Full text

, , +17

Leucettinibs, a Class of DYRK/CLK Kinase Inhibitors Inspired by the Marine Sponge Natural Product Leucettamine B

Emmanuel Deau, Mattias F. Lindberg, Frédéric Miege et al. · Journal of Medicinal Chemistry · 2023 · 32 citations · Full text

, , +17

1–5 of 14